Literature DB >> 328541

The "spastic colon" syndrome: therapeutic and pathophysiologic considerations.

F Lechin, B Van Der Dijs, A Bentolila, F Peña.   

Abstract

Low doses of d-amphetamine plus propranolol rapidly improved the abdominal pain in 165 "spastic colon" patients. Concomitantly, these drugs reduced the sigmoidal hypertonicity and the rectal inhibition found in the manometric studies performed in some of those patients. The sigmoidal tone and phasic activity were also decreased by anticholinergic drugs. These results suggest that a cholinergic-serotonergic hyperactivity of the myenteric plexus may be responsible for the "spastic colon" syndrome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 328541     DOI: 10.1002/j.1552-4604.1977.tb04626.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  6 in total

1.  Pathophysiology of biliary-type abdominal pain.

Authors:  Fuad Lechin; Bertha van der Dijs
Journal:  Dig Dis Sci       Date:  2007-11       Impact factor: 3.199

2.  Dopamine and distal colon motility.

Authors:  F Lechin; B van der Dus
Journal:  Dig Dis Sci       Date:  1979-01       Impact factor: 3.199

3.  Effects of dopamine and bromocriptine on colonic motility in dog.

Authors:  L Bueno; M J Fargeas; J Fioramonti; C Honde
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

Review 4.  Central nervous system plus autonomic nervous system disorders responsible for gastrointestinal and pancreatobiliary diseases.

Authors:  Fuad Lechin; Bertha van der Dijs
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

5.  Plasma neurotransmitters and cortisol in duodenal ulcer patients. Role of stress.

Authors:  F Lechin; B van der Dijs; I Rada; H Jara; A E Lechin; A Cabrera; M E Lechin; V Jimènez; F Gòmez; S Villa
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

6.  Irritable bowel syndrome, depression, and Th-1 autoimmune diseases.

Authors:  Fuad Lechin; Bertha van der Dijs
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.